Analyst firms · Raymond James · BAX
Raymond James BAX price target and rating history
Baxter International Inc. (BAX) · Health Care
Raymond James rates Baxter International Inc. (BAX) Mkt Perform with a $96 price target, as of its latest action on Jan 5, 2023. It has published 3 rating actions on BAX since January 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Mkt Perform
- Price target
- $96
- Median target, all firms
- Too few
- Actions on BAX
- 3
Raymond James price target on BAX
Every Raymond James rating on BAX
- Jan 5, 2023
- Feb 18, 2022
- Jan 4, 2022
How other firms rate BAX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Peer Perform | Oct 20, 2026 | |
| Barclays | Underweight | $20 | Oct 7, 2026 |
| Citigroup | Neutral | $28 | Jul 31, 2026 |
Questions about Raymond James and BAX
- What is Raymond James's price target for BAX?
- Raymond James's latest stated price target for Baxter International Inc. (BAX) is $96, from its action on Feb 18, 2022.
- What is Raymond James's rating on BAX?
- Raymond James rates BAX Mkt Perform, a neutral rating, as of Jan 5, 2023.
- When did Raymond James last change its view on BAX?
- On Jan 5, 2023, Raymond James downgrades to Mkt Perform from Outperform.
More BAX rating histories
All Raymond James ratingsBAX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.